BidaskClub upgraded shares of LeMaitre Vascular (NASDAQ:LMAT) from a hold rating to a buy rating in a research note released on Wednesday morning.
A number of other analysts have also recently weighed in on the company. Zacks Investment Research cut LeMaitre Vascular from a buy rating to a hold rating in a research report on Wednesday, January 3rd. Stifel Nicolaus reaffirmed a buy rating on shares of LeMaitre Vascular in a research report on Sunday, October 29th. Canaccord Genuity reduced their price target on LeMaitre Vascular from $30.00 to $29.00 and set a hold rating for the company in a research report on Friday, October 27th. Benchmark cut LeMaitre Vascular from a buy rating to a hold rating in a research report on Friday, October 27th. Finally, First Analysis cut LeMaitre Vascular from an overweight rating to an equal weight rating and set a $34.00 price target for the company. in a research report on Friday, October 27th. Six investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. LeMaitre Vascular currently has an average rating of Hold and a consensus target price of $32.20.
Shares of LeMaitre Vascular (LMAT) opened at $34.29 on Wednesday. LeMaitre Vascular has a 12-month low of $19.82 and a 12-month high of $39.88. The firm has a market capitalization of $662.33, a PE ratio of 44.65, a price-to-earnings-growth ratio of 2.64 and a beta of 0.53.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://sportsperspectives.com/2018/02/08/bidaskclub-upgrades-lemaitre-vascular-lmat-to-buy.html.
LeMaitre Vascular Company Profile
LeMaitre Vascular, Inc is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.
Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.